trial
as of 2026-07-01Prucalopride for Cognitive Functioning in Schizophrenia
NCTId NCT06474286
at a glance
— · Not Yet Recruiting
Enrollment 34 (estimated)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2026-12-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Not Yet Recruiting
Enrollment
34 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2026-07-31
Primary completion
2026-12-31
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Drugs
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
K S Hegde Medical AcademyCollaborator
Investigators
1
Vishwajit Laxmikant Nimgaonkar, MD PhDPrincipal Investigator
Sites
1 total
Mangalore, India
Facts & assertions
4 sourced
Enrollment
34
Phase
NA
Primary Completion Date
2026-12-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator